Title: Global Study Reveals: Resveratrol from Grapes Inhibits Cancer Stem Cell Growth
Title: Global Study Reveals: Resveratrol from Grapes Inhibits Cancer Stem Cell Growth
Meta Description: A global study reveals Resveratrol inhibits cancer stem cell growth. Blue Eyes Biotech supplies 98% pure Trans-Resveratrol for advanced formulations.
Article:
A comprehensive global research initiative, with findings published in Cell Stem Cell in 2024, has identified Resveratrol as a potent natural
inhibitor of cancer stem cells (CSCs). CSCs are a subpopulation of cells within tumors that are responsible for recurrence and metastasis,
as they are largely resistant to conventional therapies. The study demonstrated that resveratrol targets multiple signaling pathways crucial
for CSC self-renewal and survival, including the Wnt/β-catenin and STAT3 pathways, effectively reducing the tumor-initiating capacity of
these cells. This positions resveratrol as a critical ingredient for preventing relapse. Blue Eyes Biotech CO., Ltd. supplies a premium,
98% pure Trans-Resveratrol, sourced from Japanese Knotweed (Polygonum cuspidatum), which provides a sustainable and potent source
of this compound. Our manufacturing process carefully controls temperature and light to prevent the conversion of the bioactive
trans-isomer to the less active cis-form. For nutraceutical companies aiming to develop products for long-term survivorship and recurrence
prevention, targeting cancer stem cells is the next frontier. Blue Eyes Biotech provides the high-purity resveratrol necessary for such
advanced applications, backed by HPLC analysis confirming the isomeric purity. Our technical team can advise on formulation strategies
to overcome resveratrol's bioavailability challenges. By incorporating our high-purity Resveratrol, brands can create sophisticated
supplements that address the root cause of cancer recurrence, offering a significant advancement in long-term cancer care. For technical
data and samples, contact us at [email protected].
